Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,171.9
30.1 (0.96%)

 

  • STI Straits Times Index
    3,171.9
    30.1 (0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.3
    -3.1 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,257.6
    783.7 (3.08%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,411.7
    50.1 (1.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,782.4
    200.8 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,130.2
    41.7 (0.68%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 861.7M
  • Value: 966.5M
  • Rise: 188
  • Fall: 134
  • Unch: 441

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
GKE0.157-0.004
CapAllianz0.003-
Golden Agri-Res0.230+0.015
Abundance Intl0.044+0.002
ISDN0.770+0.060
Geo Energy Res0.260+0.015
SingMyanmar^0.158+0.011
Sembcorp Marine0.108-0.002
Singtel2.260+0.030
Genting Sing0.815+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,762.6 +102.0
HSI 26,281.5 +807.6
HSCEI 9,403.9 +332.8
Jakarta 6,130.2 +41.7
Nikkei 225 27,782.4 +200.8
SSE Comp 3,411.7 +50.1
Shanghai A 3,575.8 +52.6
Shanghai B 256.1 +1.6
KOSPI 3,242.7 +5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VOLPARA HEALTH TECHNOLOGIES LTD VOLPARA HEALTH TECHNOLOGIES
Updated on 28 Jul 2021 (End of trading day)
Last (AUD): 1.105 Change: -0.030 High: 1.145 Remarks: -
Change (%): -2.64 Low: 1.105
Open 1.140 Yesterday's Close 1.135
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 451,648 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.06498 Trailing EPS (AUD) e -0.06498 NAV (AUD) b 0.2664
PE a - Trailing PE f - Price / NAV b 4.1479
Dividend (AUD) d - Cash In Hand (AUD) g 0.0288 Issued & Paid-up Shares c 251,315,000
Dividend Yield (%) d - Price / Cash In Hand g 38.368 Treasury Shares h -
Beta - 75 Daysi 1.063 R-Squared - 75 Days(%)i 7.21 Market Cap (M) 277.703
Beta - 500 Daysi 1.034 R-Squared - 500 Days (%)i 4.00 Enterprise Value (M) 253.008
Piotroski F Score 2 Exchange Code VHT Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 38.64 Free Float (%) 75.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 May 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VOLPARA HEALTH TECHNOLOGIES LTD ASX 277.703 - - 4.1479 -
Industry Medical Specialties ASX 2,279.370 84.816 99.351 10.1303 0.807
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 17,244.819 35.230 35.230 12.3310 1.395
Local Peer COCHLEAR LTD ASX 16,014.605 - - 9.7567 0.656
Local Peer EBOS GROUP ASX 4,824.927 29.689 27.777 3.4941 2.591
Local Peer NANOSONICS LIMITED ASX 1,534.457 151.353 260.519 11.7715 -
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 597.304 - - -418.3673 -
Local Peer AROA BIOSURGERY LTD ASX 356.775 - - 6.6349 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 271.607 716.165 - 4.0532 0.483
Local Peer INCANNEX HEALTHCARE LTD ASX 261.819 - - 22.2727 -
Local Peer SOMNOMED LIMITED ASX 192.829 - - 5.7347 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 188.071 - - 14.5892 -
Local Peer LUMOS DIAGNOSTICS HOLDINGS LIMITED ASX 172.675 - - - -
Local Peer CYCLOPHARM LIMITED ASX 158.737 - - 9.2744 0.506
Other Local Peers IMPEDIMED LIMITED (ASX), MICRO-X LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OPTISCAN IMAGING (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), RESONANCE HEALTH LTD (ASX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ANALYTICA (ASX)
Global Peer ABBOTT LABORATORIES NYSE 214,142.346 47.874 33.718 - 1.266
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 207,624.902 32.569 26.202 5.9223 0.168
Global Peer DANAHER CORP NYSE 209,087.032 59.569 59.569 5.2949 0.245
Global Peer MEDTRONIC PLC NYSE 175,405.828 48.643 48.643 3.4107 1.779
Global Peer INTUITIVE SURGICAL INC NASDAQ 115,482.430 108.884 71.171 10.6558 -
Global Peer STRYKER CORP NYSE 101,224.653 63.305 71.893 7.4970 0.875
Global Peer BECTON DICKINSON & CO NYSE 73,716.800 96.111 44.949 2.9696 1.259
Global Peer EDWARDS LIFESCIENCES CORP NYSE 68,417.368 83.091 80.396 14.6868 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,551.941 - 451.412 4.1066 -
Global Peer IDEXX LABORATORIES INC NASDAQ 59,319.549 101.963 87.984 84.4171 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), NOVOCURE LTD (NASDAQ), HOLOGIC INC (NASDAQ), INSULET CORPORATION (NASDAQ), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT-100 (HKEx), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ANGELALIGN (HKEx), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), HARTA (Bursa), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CARDIOFLOW-B (HKEx), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), AXONICS INC (NASDAQ), VENUS MEDTECH-B (HKEx), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), PEIJIA-B (HKEx), CYTEK BIOSCIENCES INC (NASDAQ), LIFETECH SCI (HKEx), THE BEAUTY HEALTH COMPANY (NASDAQ), GLAUKOS CORPORATION (NYSE), SUPERMX (Bursa), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), ZYLOXTB-B (HKEx), AVANOS MEDICAL INC (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), KANGJI MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), AK MEDICAL (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), VAREX IMAGING CORPORATION (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CRYOLIFE INC (NYSE), BIOVENTUS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), 908 DEVICES INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CHUNLI MEDICAL (HKEx), MODERN DENTAL (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), KDL MEDICAL (HKEx), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), BASECARE-B (HKEx), ZYNEX INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NEUROPACE INC (NASDAQ), PAVMED INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SOLITON INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), SIENTRA INC (NASDAQ), IRADIMED CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), MISONIX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CVRX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), LUCIRA HEALTH INC (NASDAQ), YESTAR HEALTH (HKEx), NEURONETICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), QUOTIENT LTD (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), INVACARE CORP (NYSE), UGHealthcare (SGX), PW MEDTECH (HKEx), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TELA BIO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), KELFRED (HKEx), FONAR CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VINCENT MED (HKEx), CHECK-CAP LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), NEUROMETRIX INC (NASDAQ), LENSAR INC (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ADVENTA (Bursa), ELECTROCORE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), YUNNAN ENERGY (HKEx), RGTBHD (Bursa), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), Biolidics (SGX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), LKL (Bursa), DAXOR CORP (NYSE American), NANOVIBRONIX INC (NASDAQ), Yunnan Energy (SGX), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), DYNATRONICS CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), LIFE HEALTHCARE (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), CYANOTECH CORP (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-3.49 %
10 Days --0.095
-7.92 %
20 Days --0.055
-4.74 %
Medium Term Return 3 Months --0.175
-13.67 %
6 Months --0.375
-25.34 %
1 Year --0.230
-17.23 %
Long Term Return 2 Years --0.505
-31.37 %
3 Years -+0.310
+38.99 %
5 Years -+0.723
+189.27 %
Annualised Return Annualised --
+23.67 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.050 - 1.715 Change From 1 Year Low +0.055 % Change From 1 Year Low (%) +5.24
Change From 1 Year High -0.610 % Change From 1 Year High (%) -35.57
2 Years Range 0.790 - 2.170 Change From 2 Years Low +0.315 % Change From 2 Years Low (%) +39.87
Change From 2 Years High -1.065 % Change From 2 Years High (%) -49.08
5 Years Range 0.298 - 2.170 Change From 5 Years Low +0.807 % Change From 5 Years Low (%) +270.81
Change From 5 Years High -1.065 % Change From 5 Years High (%) -49.08
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. Its products include VolparaDensity and VolparaEnterprise DDP. The company was founded by Martin Yaffe and Nico Karssemeijer in 2009 and is headquartered in Wellington, New Zealand.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jul 2021 1.140 1.145 1.105 1.105 451,648 -
27 Jul 2021 1.160 1.175 1.130 1.135 497,532 -
26 Jul 2021 1.140 1.160 1.140 1.155 141,246 -
23 Jul 2021 1.140 1.155 1.130 1.140 100,671 -
22 Jul 2021 1.150 1.155 1.135 1.145 192,158 -
21 Jul 2021 1.150 1.155 1.130 1.145 556,142 -
20 Jul 2021 1.160 1.160 1.135 1.140 227,122 -
19 Jul 2021 1.170 1.180 1.145 1.160 219,110 -
16 Jul 2021 1.160 1.165 1.140 1.140 195,213 -
15 Jul 2021 1.200 1.200 1.160 1.160 299,728 -
14 Jul 2021 1.170 1.200 1.170 1.200 334,013 -
13 Jul 2021 1.140 1.190 1.140 1.180 372,175 -
12 Jul 2021 1.155 1.180 1.140 1.140 312,750 -
09 Jul 2021 1.170 1.170 1.150 1.160 128,365 -
08 Jul 2021 1.175 1.185 1.150 1.170 211,155 -
07 Jul 2021 1.190 1.195 1.165 1.180 194,615 -
06 Jul 2021 1.210 1.210 1.180 1.180 302,926 -
05 Jul 2021 1.230 1.235 1.200 1.210 214,058 -
02 Jul 2021 1.200 1.230 1.200 1.220 327,466 -
01 Jul 2021 1.160 1.200 1.155 1.190 382,908 -
30 Jun 2021 1.140 1.160 1.135 1.160 889,763 -
29 Jun 2021 1.170 1.170 1.130 1.150 579,328 -
Summary
Current 2 Weeks
(15 Jul 2021 to 28 Jul 2021)
1.200 1.200 1.105 1.105 2,880,570 -
Previous 2 Weeks
(01 Jul 2021 to 14 Jul 2021)
1.160 1.200 1.105 1.200 2,780,431 -
4 Weeks from
(02 Jun 2021 to 30 Jun 2021)
1.300 1.300 1.105 1.160 9,611,034 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.